YUCAIPA, Calif, July 22, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (PinkSheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8 billion respiratory market, reported revenues that increased 1,139%, from $10,401 during the first quarter of 2009 to $128,917 during the first quarter of 2010. Shareholders from companies such as Paradigm Medical Industries Inc. (PDMI) and Cardiovascular Systems Inc. (CSII) are taking notice of this uptrend.
